Tag Archives: Methylphenidate

Pharmacological Treatment of Dementia

General guidelines for psychotropic medication use in frail elderly patients are applicable. Systematic evidence to support the effectiveness of particular psychotropic drugs in dementia patients is limited. Therefore, choice of drug class may be based on clinical evidence, and choice of agent is often based on the side-effect profile and on the characteristics of a… Read More »

Pharmacotherapy of Adult ADHD

Originally conceptualized as a disorder of childhood (), attention deficit hyperactivity disorder (ADHD) is increasingly recognized in adults. attention deficit hyperactivity disorder is estimated to affect 2-9% of school-age children and up to 5% of adults (). Although some investigators question the persistence of attention deficit hyperactivity disorder in adulthood (), long-term controlled follow-up studies… Read More »

Stimulants in the treatment of adults with ADHD

Stimulant treatment of adults with attention deficit hyperactivity disorder can be characterized as follows. Stimulants represent the first-line pharamcotherapy for attention deficit hyperactivity disorder in adults. The two main types of stimulants, methylphenidate and amphetamine compounds, have different effects and are metabolized differently. Methylphenidate does not show up on urine drug screens. Stimulants are not… Read More »

Nonstimulant medications in the treatment of adults with ADHD

Here are some important points regarding nonstimulants in the treatment of adults with ADHD. Tricyclic antidepressants and bupropion are second-line therapies. Antidepressant dosing of the agents appears necessary for attention deficit hyperactivity disorder efficacy. Serotonergic medications do not appear effective in the treatment of core attention deficit hyperactivity disorder symptoms but may be useful for… Read More »

Are the other conditions that frequently accompany ADHD evident in childhood, or do they develop later due to environmental influences?

Coexisting conditions appear early on in the picture of attention deficit hyperactivity disorder, but how early is the critical question. In one study comparing 165 four- to six-year-olds to 381 seven- to nine-year-olds, similar rates of impairment were found in school, social, and overall functioning. We can also look at a more recent study designed… Read More »

Narcolepsy and Other Disorders of Excessive Daytime Sleepiness

Narcolepsy is a prime example of a disorder with dysfunction of a specific sleep state, in this case REM sleep. Isolated fragments of REM sleep intrude into wakefulness, and the result is the characteristic symptoms that invariably cause excessive daytime sleepiness. Narcolepsy in humans was first described in 1880 by the French neurologist Gelineau. Since… Read More »

What medications are used to treat ADHD in women and girls?

Research and clinical experience have shown that stimulant medications are the most effective first-line treatment for ADHD in both males and females. Currently, there are many medication formulations, including stimulants (methylphenidate and amphetamine preparations) and nonstimulants for the treatment of attention-deficit/hyperactivity disorder. Although a few skeptics continue to voice concerns over the prescription of medication… Read More »

Term “Psychotropic Drugs”

Question. I’m a medical student who is trying to find out exactly what the term “psychotropic drugs” includes. Does it cover marijuana and other street drugs, or is it only for mood-altering drugs (developed by pharmaceutical companies) without euphoric effects? What is the true definition? Answer. Good question, but a bit like trying to nail… Read More »

Information about ADHD for Patients and Families

Attention-deficit/hyperactivity disorder (ADHD) is a common psychiatric disorder in young and school-aged children. However, it is not merely a childhood disorder. In recent years, an increasing number of adults have been diagnosed with ADHD, raising some concern that it may be overdiagnosed. Estimates of the prevalence (i.e., percentage of the population affected) of attention-deficit/hyperactivity disorder… Read More »